Furthermore, our study indicated that ADNP and GDF11 m6A methylation levels may be closely related to impaired BMSC function in T2DM patients and could thus be utilised as targets in the future to enhance function and improve the success of implantation in patients with T2DM. The gene discussed is ADNP; the disease is type 2 diabetes mellitus.